Alnylam Pharmaceuticals to Present New Drug Application for Cardiomyopathy of ATTR Amyloidosis
1 Mins read
Alnylam Pharmaceuticals Inc. announced on Wednesday that its stock will be temporarily halted on Nasdaq while a regulatory advisory committee reviews its…